13F
中

CGON CG ONCOLOGY INC

2026Q1 · CUSIP 156944100 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
232
Δ holders QoQ
+35
Breadth percentile
Top 8%
Whale holders
121
Δ whales
+25
Inst. holding value
$5.8B
New positions
64
Closed positions
29
Price momentum (1Q)
+16.8%
Put / Call
4/9

Breadth history (34 quarters)

2024Q2: Δ+16 · h=112 2024Q3: Δ+10 · h=122 2024Q4: Δ+20 · h=142 2025Q1: Δ+2 · h=144 2025Q2: Δ+20 · h=164 2025Q3: Δ+13 · h=177 2025Q4: Δ+20 · h=197 2026Q1: Δ+35 · h=232 2024Q2: holders=112 2024Q3: holders=122 2024Q4: holders=142 2025Q1: holders=144 2025Q2: holders=164 2025Q3: holders=177 2025Q4: holders=197 2026Q1: holders=232 -35 -17.5 +0 +17.5 +35 100172244 24Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 8% — —
2025Q2 Top 16% +56.9% +111.3%
2024Q2 Top 17% +3.7% -19.6%

Options Sentiment

Put holders
4
QoQ: +1
Call holders
9
QoQ: +2

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-2.34
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
+666.0%
Quarterly Revenue & EPS (4Y)
2023-03-31: $0M 2023-06-30: $0M 2023-09-30: $0M 2023-12-31: $0M 2024-03-31: $1M 2024-06-30: $0M 2024-09-30: $0M 2024-12-31: $0M 2025-03-31: $0M 2025-06-30: $0M 2025-09-30: $2M 2025-12-31: $2M 2026-03-31: $1M 2024-03-31: EPS -0.36 2024-06-30: EPS -0.28 2024-09-30: EPS -0.30 2024-12-31: EPS -0.47 2025-03-31: EPS -0.45 2025-06-30: EPS -0.54 2025-09-30: EPS -0.57 2025-12-31: EPS -0.52 2026-03-31: EPS -0.71 0M 1M 2M $M -0.78 -0.39 0.00 2023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)